Montes Archimedes Acquisition Corp. (MAAC)
|Net Income (ttm)||n/a|
|Trading Day||May 7|
|Day's Range||9.89 - 9.93|
|52-Week Range||9.61 - 10.87|
A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal: Roviant Sciences announ...
Montes Archimedes Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Warrants...
MENLO PARK, Calif., Nov. 25, 2020 /PRNewswire/ -- Montes Archimedes Acquisition Corp. (Nasdaq: MAACU) (the "Company") announced that, commencing November 27, 2020, holders of the units sold in the Compa...
U.S. IPO Weekly Recap: Healthcare Dominates A 7 IPO Week
MENLO PARK, Calif., Oct. 6, 2020 /PRNewswire/ -- Montes Archimedes Acquisition Corp (the "Company" or "Montes Archimedes"), a special purpose acquisition company formed for the purpose of entering into ...
Montes Archimedes Acquisition Corp. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in Menlo Park, California.
|IPO Date |
Oct 7, 2020
|Stock Exchange |
|Ticker Symbol |